BG
IOVA icon

BlackRock Group’s Iovance Biotherapeutics IOVA Stock Holding History

BlackRock Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.8M Buy
690,300
+1,428
+0.2% +$9.83K ﹤0.01% 1218
2016
Q3 		$5.67M Buy
688,872
+675,700
+5,130% +$5.72M ﹤0.01% 1068
2016
Q2 		$107K Sell
13,172
-204
-2% -$1.28K ﹤0.01% 2775
2016
Q1 		$68K Buy
13,376
+5,522
+70% +$30.2K ﹤0.01% 2858
2015
Q4 		$60K Sell
7,854
-272
-3% -$1.89K ﹤0.01% 2795
2015
Q3 		$47K Sell
8,126
-20,365
-71% -$159K ﹤0.01% 2858
2015
Q2 		$262K Buy
28,491
+11,656
+69% +$130K ﹤0.01% 2505
2015
Q1 		$204K Buy
+16,835
New +$190K ﹤0.01% 2492

Other funds holding IOVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return